当前位置: X-MOL 学术Genes Dev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities
Genes & Development ( IF 7.5 ) Pub Date : 2023-11-01 , DOI: 10.1101/gad.351051.123
Carlos Mendez-Dorantes 1, 2, 3 , Kathleen H Burns 1, 2, 3
Affiliation  

Long interspersed element 1 (LINE-1) is the only protein-coding transposon that is active in humans. LINE-1 propagates in the genome using RNA intermediates via retrotransposition. This activity has resulted in LINE-1 sequences occupying approximately one-fifth of our genome. Although most copies of LINE-1 are immobile, ∼100 copies are retrotransposition-competent. Retrotransposition is normally limited via epigenetic silencing, DNA repair, and other host defense mechanisms. In contrast, LINE-1 overexpression and retrotransposition are hallmarks of cancers. Here, we review mechanisms of LINE-1 regulation and how LINE-1 may promote genetic heterogeneity in tumors. Finally, we discuss therapeutic strategies to exploit LINE-1 biology in cancers.

中文翻译:


LINE-1 逆转录转座及其在癌症中的失调:对治疗机会的影响



长散布元件 1 (LINE-1) 是唯一在人类中具有活性的蛋白质编码转座子。 LINE-1 使用 RNA 中间体通过逆转录转座在基因组中繁殖。这一活动导致 LINE-1 序列占据了我们基因组的大约五分之一。尽管 LINE-1 的大多数拷贝是不可移动的,但~100 个拷贝具有逆转录转座能力。逆转录转座通常受到表观遗传沉默、DNA 修复和其他宿主防御机制的限制。相反,LINE-1 过度表达和逆转录转座是癌症的标志。在这里,我们回顾了 LINE-1 的调控机制以及 LINE-1 如何促进肿瘤的遗传异质性。最后,我们讨论了利用 LINE-1 生物学治疗癌症的治疗策略。
更新日期:2023-11-01
down
wechat
bug